S. M. Eslami, S. Nikfar, M. Ghasemi, and M. Abdollahi, “Does Evolocumab, as a PCSK9 Inhibitor, Ameliorate the Lipid Profile in Familial Hypercholesterolemia Patients? A Meta-Analysis of Randomized Controlled Trials”, J Pharm Pharm Sci, vol. 20, pp. 81–96, Apr. 2017.